These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36294754)

  • 1. Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota.
    Zhang L; Jacobson PA; Johnson ANK; Gregornik DB; Johnson SG; McCarty CA; Bishop JR
    J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing pharmacogenomic literacy in China through validation of the Chinese version of the Minnesota Assessment of Pharmacogenomic Literacy.
    Zhang L; Zhou S; Allen JD; Wang F; Pittenger AL; Bishop JR
    Clin Transl Sci; 2023 Nov; 16(11):2356-2368. PubMed ID: 37721333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL).
    Allen JD; Zhang L; Johnson ANK; Jacobson PA; McCarty CA; Pittenger AL; Bishop JR
    J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Do Students in Pharmacy and Medicine Think About Pharmacogenomics and Personalized Medicine Education? Awareness, Attitudes, and Perceptions in Malaysian Health Sciences.
    Siamoglou S; Koromina M; Moy FM; Mitropoulou C; Patrinos GP; Vasileiou K
    OMICS; 2021 Jan; 25(1):52-59. PubMed ID: 33170085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics education, research and clinical implementation in the state of Minnesota.
    Bishop JR; Huang RS; Brown JT; Mroz P; Johnson SG; Allen JD; Bielinski SJ; England J; Farley JF; Gregornik D; Giri J; Kroger C; Long SE; Luczak T; McGonagle EJ; Ma S; Matey ET; Mandic PK; Moyer AM; Nicholson WT; Petry N; Pawloski PA; Schlichte A; Schondelmeyer SW; Seifert RD; Speedie MK; Stenehjem D; Straka RJ; Wachtl J; Waring SC; Ness BV; Zierhut HA; Aliferis C; Wolf SM; McCarty CA; Jacobson PA
    Pharmacogenomics; 2021 Jul; 22(11):681-691. PubMed ID: 34137665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing disparities in pharmacogenomics through rural and underserved workforce education.
    Brown JT; McGonagle E; Seifert R; Speedie M; Jacobson PA
    Front Genet; 2022; 13():1082985. PubMed ID: 36726715
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine.
    Tsuji D; Saito Y; Mushiroda T; Miura M; Hira D; Terada T
    J Clin Pharm Ther; 2021 Jun; 46(3):649-657. PubMed ID: 33555613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A qualitative approach to assess the opinion of physicians about the challenges and prospects of pharmacogenomic testing implementation in clinical practice in Greece.
    Koufaki MI; Patrinos GP; Vasileiou KZ
    Hum Genomics; 2024 Jul; 18(1):82. PubMed ID: 39030587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward Integration of Pharmacogenomic Tests into Daily Clinical Practice: A General Survey for Polish Healthcare Workers.
    Tafazoli A; Kitlas Golińska A; Mnich K; Amirabadizadeh A; Clark Marquez J; Miltyk W
    Med Sci Monit; 2023 Jun; 29():e940119. PubMed ID: 37303136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System.
    Mroz P; Michel S; Allen JD; Meyer T; McGonagle EJ; Carpentier R; Vecchia A; Schlichte A; Bishop JR; Dunnenberger HM; Yohe S; Thyagarajan B; Jacobson PA; Johnson SG
    Front Genet; 2021; 12():712602. PubMed ID: 34745204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
    Tuteja S; Haynes K; Zayac C; Sprague JE; Bernhardt B; Pyeritz R
    Per Med; 2013 Nov; 10(8):793-800. PubMed ID: 24409195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
    Slomp C; Morris E; Edwards L; Hoens AM; Landry G; Riches L; Ridgway L; Bryan S; Austin J
    Can J Psychiatry; 2023 Jun; 68(6):436-452. PubMed ID: 36437757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
    Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system.
    Van Heukelom J; Morgan J; Massmann A; Jacobsen K; Petry NJ; Baye JF; Frear S; Schultz A
    Front Pharmacol; 2023; 14():1274165. PubMed ID: 38035031
    [No Abstract]   [Full Text] [Related]  

  • 15. Using Pharmacogenomic Testing in Primary Care: Protocol for a Pilot Randomized Controlled Study.
    Manzor Mitrzyk B; Kadri R; Farris KB; Ellingrod VL; Klinkman MS; Ruffin Iv MT; Plegue MA; Buis LR
    JMIR Res Protoc; 2019 Aug; 8(8):e13848. PubMed ID: 31429417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of stakeholders' intention to adopt pharmacogenomic.
    Mustapa MAC; Amin L; Mahadi Z
    Pharmacogenomics J; 2020 Dec; 20(6):801-812. PubMed ID: 32457399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients.
    Virelli CR; Ebrahimi M; Mohiuddin AG; Tomasi J; Lisoway AJ; Herbert D; Marshe VS; Kidd SA; Ferenbok J; Kennedy JL
    J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38248723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes toward pharmacogenetics in patients undergoing
    Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
    Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives.
    Bhatt M; Peshkin BN; Kazi S; Schwartz MD; Ashai N; Swain SM; Smith DM
    Pharmacogenomics; 2023 Nov; 24(16):859-870. PubMed ID: 37942634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.